We found that free glucose decreased dramatically and the glycogen level was significantly elevated in the liver of T2D mice treated with IHMT-MST1-39 or metformin, and most significantly in combination group (Supplementary Fig. S9a, b). Here, MST1 is linked to type 2 diabetes mellitus.